Mumbai: The Maharashtra government on Friday capped rates of Mucormycosis treatment at private hospitals.  However, the treatment for black fungus in the state-run hospital is free of cost as informed by the state government last month. 

The order issued under the Epidemic Diseases Act, the Disaster Management Act, and other related legislation states that the condition requires high-end treatment, both in its management and surgeries. It adds that the treatment rates are being capped to “redress the grievances regarding the inordinate amount of money charged by Healthcare Providers” from patients who are not covered by any health insurance and those who have exhausted their insurance cover. 


 The first report of the Nepalese mutation of the virus was announced in the US during a press conference on Thursday. Some cases have also been identified in India, Japan, Portugal, and the UK.  

Download Lalluram App to read all the Latest news

Areas in the state have been classified under A, B, and C categories and different rates have been fixed for the three. Mumbai, Pune, and Nagpur fall under Cat A according to which the daily treatment rate for ward patients has been capped at Rs 4,000. The rates for ICU without ventilator and ICU with ventilator support have been fixed at Rs 7,500 and Rs 9,000, respectively.

The daily rate for ward treatment has been fixed at Rs 3,000, while rates for ICU with and without ventilator support have been capped at ₹ 5,500 and ₹ 6,700, respectively for Cat B that covers hospitals in  Nasik, Amravati, Aurangabad, Bhiwandi, Solapur, Kolhapur, Vasai Virar, Malegaon, Nanded, and Sangli.

The remaining areas of that state have been classified under Cat C, for which the ward rates are capped at Rs 2,400 and Rs 4,500 for ICU without the ventilator and Rs 5,400 for ICU with ventilator support. 

The order warns that if a healthcare unit is found violating the guidelines, an offense will be registered under the Indian Penal Code and its registration may be cancelled.

Read About: Delta+K417N Variant Affected Nearly 100 Everest Climbers; detected in US

https://en.lalluram.com/deltak417n-variant-affected-nearly-100-everest-climbers-detected-in-us/